Brevibloc
Evaluates the hemodynamic outcomes with Brevibloc premixed injection (esmolol hydrochloride) in patients with supraventricular tachycardia/atrial fibrillation in medical and neurological intensive care units in the United States. Principal Investigator: Gopinath Upamaka, MD, FACC Contact the research coordinator: Tamithy Huber |